New Zealand vs Serbia: Treatment success rate for patients treated for MDR-TB
New Zealand
100.0%
in 2022
Serbia
100.0%
in 2022
New Zealand rank
1st
Serbia rank
1st
Treatment success rate for patients treated for MDR-TB over time
- New Zealand
- Serbia
How they compare
New Zealand currently reports 100.0% against 100.0% in Serbia, a difference of 0.0%.
The two have swapped places 6 times across 12 shared years of data; in 2009 it was Serbia ahead.
New Zealand ranks 1st and Serbia ranks 1st of 163 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 60.0% | 17.0% | Serbia |
| 2010s | 58.2% | 67.8% | 9.5% | Serbia |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, New Zealand or Serbia?
- New Zealand, at 100.0% against 100.0% in Serbia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between New Zealand and Serbia?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Serbia?
- 12 years are reported by both, from 2009 to 2022.
- How do New Zealand and Serbia rank globally for treatment success rate for patients treated for mdr-tb?
- New Zealand ranks 1st and Serbia ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.